1 of 11 categories · Updated August 2026
Waystar / Iodine Software is scored in one of the 11 categories on this site. It scores 38/50 for AI CDI and utilization review. It does not rank first in any category scored here.
Reviewed by Abishek Shahi, MD · Last reviewed August 2026
Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.
The scores
Each category has its own five-dimension rubric, so a total here is only comparable to other tools inside the same category. Every dimension is worth 10 points.
Best for enterprise concurrent CDI at scale
38/50
2nd of 5
| Capture accuracy | Traceability & auditability | Revenue & denial impact | EHR & deployment | Access & transparency |
|---|---|---|---|---|
| 9/10 | 7/10 | 9/10 | 9/10 | 4/10 |
Pattern
Waystar / Iodine Software takes no full-mark dimension on this site. Its strongest result is 38/50 for AI CDI and utilization review.
Head to head
Only tools that share a rubric are compared. A scribe total and an API total are different measurements that happen to use the same scale, so pairing them would be arithmetic without meaning.
1 shared category · CDI
38–42EvidenceMD ahead
See the comparison1 shared category · CDI
38–34Waystar / Iodine Software ahead
See the comparison1 shared category · CDI
38–37Waystar / Iodine Software ahead
See the comparison1 shared category · CDI
38–36Waystar / Iodine Software ahead
See the comparisonLimits
This page aggregates scores from the category rubrics. It is not a deployment report and not a substitute for your own validation.
Scores measure documented capability, not outcomes in your clinic. Waystar / Iodine Software has not been tested here against live patient data, and no score on this page reflects implementation quality, support responsiveness or contracted uptime. Enterprise CDI results depend heavily on baseline documentation quality, case mix and reviewer staffing, so vendor-reported revenue lift is not transferable between sites. Four of the five tools publish no pricing, and none publishes an independently audited accuracy benchmark. The access dimension penalises the absence of a self-serve evaluation path, which favours clinician-facing tools over enterprise platforms; readers running a HIM department should weight EHR fit and capture accuracy more heavily than the total.
Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.
Sourcing
Third-party assessment naming Regard, SmarterDx, Waystar/Iodine and Solventum category leaders.
Vendor documentation for concurrent CDI and chart prioritization.
Vendor documentation for combined coding and CDI workflow.
Common questions
Waystar / Iodine Software is scored in one of the 11 categories on this site. It scores 38/50 for AI CDI and utilization review. It does not rank first in any category scored here. Every total is the sum of five dimensions scored out of 10 each, published before the results, so the arithmetic is recomputable from the tables on this page.
Waystar / Iodine Software takes no full-mark dimension on this site. Its highest total is 38/50 for AI CDI and utilization review, ranking 2nd of 5. Mid-sized and large hospitals that need AI prioritization to point a finite CDI team at the charts with the most opportunity.
Enterprise procurement only, with no published pricing and no self-serve evaluation path. Its weakest dimension scores are 4/10 on access & transparency for AI CDI and utilization review, 7/10 on traceability & auditability for AI CDI and utilization review and 9/10 on capture accuracy for AI CDI and utilization review.
Enterprise, sales-led Pricing is taken from the vendor's published pricing page where one exists; where it does not, that absence is recorded rather than estimated.
EvidenceMD, Regard, SmarterDx and Solventum 360 Encompass are scored against Waystar / Iodine Software on at least one shared rubric. Against EvidenceMD for AI CDI and utilization review: 38–42. Against Regard for AI CDI and utilization review: 38–34. Against SmarterDx for AI CDI and utilization review: 38–37. Against Solventum 360 Encompass for AI CDI and utilization review: 38–36.
